ATXN3L
Basic information
Region (hg38): X:13318647-13320053
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ATXN3L gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 12 | 13 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 12 | 2 | 0 |
Variants in ATXN3L
This is a list of pathogenic ClinVar variants found in the ATXN3L region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
X-13318985-CTTG-C | Likely benign (Mar 01, 2023) | |||
X-13318988-G-A | not specified | Conflicting classifications of pathogenicity (Dec 18, 2023) | ||
X-13319002-G-T | not specified | Uncertain significance (May 14, 2024) | ||
X-13319070-T-A | Intellectual disability | Likely benign (Dec 01, 2017) | ||
X-13319100-G-A | not specified | Uncertain significance (Oct 06, 2022) | ||
X-13319157-C-T | not specified | Likely benign (May 27, 2022) | ||
X-13319172-T-C | not specified | Conflicting classifications of pathogenicity (Feb 28, 2024) | ||
X-13319240-G-A | not specified | Uncertain significance (Aug 02, 2022) | ||
X-13319370-G-A | not specified | Uncertain significance (Oct 05, 2022) | ||
X-13319385-C-T | not specified | Uncertain significance (Jun 16, 2024) | ||
X-13319407-T-A | not specified | Uncertain significance (Apr 07, 2022) | ||
X-13319429-A-G | not specified | Uncertain significance (Apr 29, 2024) | ||
X-13319477-G-A | not specified | Uncertain significance (May 29, 2024) | ||
X-13319531-G-A | not specified | Uncertain significance (Jan 24, 2024) | ||
X-13319571-T-C | not specified | Uncertain significance (Oct 10, 2023) | ||
X-13319574-A-G | not specified | Uncertain significance (Apr 22, 2024) | ||
X-13319628-C-T | not specified | Uncertain significance (Jan 11, 2023) | ||
X-13319637-G-C | not specified | Uncertain significance (Jan 03, 2022) | ||
X-13319718-C-A | not specified | Uncertain significance (Apr 24, 2024) | ||
X-13319735-T-C | not specified | Uncertain significance (Mar 29, 2022) | ||
X-13319741-G-T | not specified | Uncertain significance (Mar 01, 2023) | ||
X-13319786-T-C | not specified | Uncertain significance (Mar 26, 2024) | ||
X-13319822-T-G | not specified | Uncertain significance (Dec 21, 2022) | ||
X-13319859-C-T | not specified | Uncertain significance (Mar 28, 2024) | ||
X-13319888-T-C | not specified | Uncertain significance (Aug 02, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ATXN3L | protein_coding | protein_coding | ENST00000380622 | 1 | 1749 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.0203 | 128 | 127 | 1.01 | 0.00000914 | 2371 |
Missense in Polyphen | 24 | 27.738 | 0.86523 | 559 | ||
Synonymous | 0.155 | 49 | 50.4 | 0.972 | 0.00000402 | 626 |
Loss of Function |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | ||
East Asian | ||
Finnish | ||
European (Non-Finnish) | ||
Middle Eastern | ||
South Asian | ||
Other |
dbNSFP
Source:
- Function
- FUNCTION: Deubiquitinating enzyme that cleaves both 'Lys-48'- linked and 'Lys-63'-linked poly-ubiquitin chains (in vitro).;
- Pathway
- Protein processing in endoplasmic reticulum - Homo sapiens (human);Josephin domain DUBs;Post-translational protein modification;Metabolism of proteins;Deubiquitination
(Consensus)
Recessive Scores
- pRec
- 0.104
Intolerance Scores
- loftool
- 0.801
- rvis_EVS
- 0.82
- rvis_percentile_EVS
- 87.87
Haploinsufficiency Scores
- pHI
- 0.209
- hipred
- N
- hipred_score
- 0.267
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0860
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- protein deubiquitination
- Cellular component
- nucleus;cytosol
- Molecular function
- thiol-dependent ubiquitin-specific protease activity;thiol-dependent ubiquitinyl hydrolase activity